United States · 
What does Ampersand Capital Partners invest in?
Ampersand Capital Partners invests most often at Venture and Series B (64% of the rounds on record), in sectors such as Digital-health, Iiot and Advanced Manufacturing.
Ampersand Capital Partners highlights
- 01
14 rounds on record
- 02
Mostly Venture and Series B: 64% of its rounds
- 03
Sole investor in 5 rounds, median $20M
- 04
1 exits from the portfolio
What they do
Ampersand Capital Partners is a life sciences and healthcare-focused private equity firm.From their own website
- Type
- Private equity (from a list, unverified)
- Cheque size
- Not stated
- Stages
- SeedSeries ASeries BGrowthPre-IPO
- Sectors
- Digital-healthIiotAdvanced Manufacturing
- Based in
- Boston, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first14 appearances
- 2019
1 round
- Oct
- 2015
1 round
- Jan
- 2014
1 round
- Jan
- 2011
2 rounds
- Apr
- Mar
- 2010
1 round
- Mar
- 2008
1 round
- Jan
- 2007
1 round
- Jun
- 2006
2 rounds
- Nov
- Apr
- 2004
2 rounds
- Dec
- Jun
- 2003
1 round
- Jul
- 2001
1 round
- Nov
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration3 named
DLDana L NilesCCO, Partner and COOiForm ADV
HHHerbert H HooperManaging Partner & Managing MemberiForm ADV
RARichard Alan CharpieFounder & Managing MemberiForm ADV
We also hold 72 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$3.1Bassets it managesOct 2026
Registeredinvestment adviserfull reporting to the SEC
- Legal name
- Ampersand Management LLC
- SEC number
- CRD 161522
Funds on its Form ADV
5 private funds, $2.8B in gross assets · filed Aug 2024
- Ampersand 2023 Limited PartnershipPrivate equity164 investors$1.2B
- Ampersand 2020 Limited PartnershipPrivate equity99 investors$658M
- Ampersand 2018 Limited PartnershipPrivate equity77 investors$447M
- Ampersand CF Limited PartnershipPrivate equity76 investors$443M
- Ampersand 2014 Limited PartnershipPrivate equity55 investors$7.9M
What they claim to have backed
From their own portfolio page (on their website)
1 of 1 we have independently watched raise
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
Exits from the portfolio
Companies it backed that were later bought or listed1 in all
EndecaBought by Oracle CorporationUndisclosedOct 2011
An exit counts when it came after the firm's first round in the company. From historical deal records.
Companies it bought
Acquisitions by the firm itself
Protein TechnologiesUndisclosedJun 2015
ESA BioscienceUndisclosedMay 2004